Quick Takeaways
- Shay Capital LLC filed SCHEDULE 13G for Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP).
- Disclosed ownership: 7.3%.
- Date of event: 24 Oct 2025.
Shay Capital LLC - 24 Oct 2025 SCHEDULE 13G Report for Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP)
- Filing Manager
- Shay Capital LLC
- Reporting Manager
- Shay Capital LLC
- Symbol
- NEUP
- Shares outstanding
- 2,351,082 shares
- Disclosed Ownership
- 171,629 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G
- Filing time
- 31 Oct 2025, 16:00:03 UTC
- Date of event
- 24 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Shay Capital LLC disclosed 7.3% ownership in Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share (NEUP) on 24 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Oct 2025, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Shay Capital LLC | 7.3% | 171,629 | 171,629 | 0 | Elan Foxman | Chief Financial Officer | |
| Shay Capital Holdings LLC | 7.3% | 171,629 | 171,629 | 0 | Elan Foxman | Chief Financial Officer |